Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 622

1.

Fas-L promotes the stem cell potency of adipose-derived mesenchymal cells.

Solodeev I, Meilik B, Volovitz I, Sela M, Manheim S, Yarkoni S, Zipori D, Gur E, Shani N.

Cell Death Dis. 2018 Jun 11;9(6):695. doi: 10.1038/s41419-018-0702-y.

2.

Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.

Eilam R, Segal M, Malach R, Sela M, Arnon R, Aharoni R.

Glia. 2018 May;66(5):1098-1117. doi: 10.1002/glia.23304. Epub 2018 Feb 9.

PMID:
29424049
3.

Immunological and inflammatory mapping of vascularized composite allograft rejection processes in a rat model.

Friedman O, Carmel N, Sela M, Abu Jabal A, Inbal A, Ben Hamou M, Krelin Y, Gur E, Shani N.

PLoS One. 2017 Jul 26;12(7):e0181507. doi: 10.1371/journal.pone.0181507. eCollection 2017.

4.

Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis.

Aharoni R, Rosen C, Shezen E, Bar-Lev DD, Golani O, Reisner Y, Sela M, Arnon R.

J Neuroimmunol. 2016 Dec 15;301:7-11. doi: 10.1016/j.jneuroim.2016.10.015. Epub 2016 Nov 1.

PMID:
27836179
5.

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.

Carvalho S, Levi-Schaffer F, Sela M, Yarden Y.

Br J Pharmacol. 2016 May;173(9):1407-24. doi: 10.1111/bph.13450. Epub 2016 Mar 14. Review.

6.

The effect of indole-3-carbinol on PIN1 and PIN2 in Arabidopsis roots.

Katz E, Nisani S, Sela M, Behar H, Chamovitz DA.

Plant Signal Behav. 2015;10(9):e1062200. doi: 10.1080/15592324.2015.1062200.

7.

Multimerization of ERBB2/HER2 specific aptamer leads to improved receptor binding.

Mahlknecht G, Maron R, Schechter B, Yarden Y, Sela M.

Biochem Biophys Res Commun. 2015 Sep 18;465(2):218-24. doi: 10.1016/j.bbrc.2015.07.157. Epub 2015 Aug 4.

PMID:
26248137
8.

Historic recollections: From polymers and proteins to autoimmunity and cancer.

Sela M.

Biochem Biophys Res Commun. 2015 Aug 21;464(2):379-85. doi: 10.1016/j.bbrc.2015.06.030. Epub 2015 Jun 22. Review. No abstract available.

PMID:
26111451
9.

Aptamer Targeting the ERBB2 Receptor Tyrosine Kinase for Applications in Tumor Therapy.

Mahlknecht G, Sela M, Yarden Y.

Methods Mol Biol. 2015;1317:3-15. doi: 10.1007/978-1-4939-2727-2_1.

PMID:
26072398
10.

Cancer Immunotherapy: More Is (Much) Better.

Yarden Y, Sela M.

Clin Cancer Res. 2015 Sep 15;21(18):4030-2. doi: 10.1158/1078-0432.CCR-15-0996. Epub 2015 May 27.

11.

Historical perspective: An interview with renowned Immunologist Dr. Michael Sela.

Sela M, Carafoli E.

Biochem Biophys Res Commun. 2015 Aug 21;464(2):376-8. doi: 10.1016/j.bbrc.2015.05.039. Epub 2015 May 20. No abstract available.

PMID:
26003729
12.

NOX1-induced accumulation of reactive oxygen species in abdominal fat-derived mesenchymal stromal cells impinges on long-term proliferation.

Sela M, Tirza G, Ravid O, Volovitz I, Solodeev I, Friedman O, Zipori D, Gur E, Krelin Y, Shani N.

Cell Death Dis. 2015 Apr 16;6:e1728. doi: 10.1038/cddis.2015.84.

13.

Examination of HER3 targeting in cancer using monoclonal antibodies.

Gaborit N, Abdul-Hai A, Mancini M, Lindzen M, Lavi S, Leitner O, Mounier L, Chentouf M, Dunoyer S, Ghosh M, Larbouret C, Chardès T, Bazin H, Pèlegrin A, Sela M, Yarden Y.

Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):839-44. doi: 10.1073/pnas.1423645112. Epub 2015 Jan 6.

14.

Novel high dose rate lip brachytherapy technique to improve dose homogeneity and reduce toxicity by customized mold.

Feldman J, Appelbaum L, Sela M, Voskoboinik N, Kadouri S, Weinberger J, Orion I, Meirovitz A.

Radiat Oncol. 2014 Dec 23;9:271. doi: 10.1186/s13014-014-0271-x.

15.

Relative genomic stability of adipose tissue derived mesenchymal stem cells: analysis of ploidy, H19 long non-coding RNA and p53 activity.

Ravid O, Shoshani O, Sela M, Weinstock A, Sadan TW, Gur E, Zipori D, Shani N.

Stem Cell Res Ther. 2014 Dec 17;5(6):139. doi: 10.1186/scrt529.

16.

Non-coding RNAs as the bridge between epigenetic mechanisms, lineages and domains of life.

Sela M, Kloog Y, Rechavi O.

J Physiol. 2014 Jun 1;592(11):2369-73. doi: 10.1113/jphysiol.2014.273045. Review.

17.

Clinical and microbiological characterization of localized aggressive periodontitis: a cohort study.

Oettinger-Barak O, Sela MN, Sprecher H, Machtei EE.

Aust Dent J. 2014 Jun;59(2):165-71. doi: 10.1111/adj.12165.

18.

Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.

From R, Eilam R, Bar-Lev DD, Levin-Zaidman S, Tsoory M, LoPresti P, Sela M, Arnon R, Aharoni R.

Glia. 2014 Apr;62(4):649-65. doi: 10.1002/glia.22632. Epub 2014 Jan 30.

PMID:
24481644
19.

Pioneer of hematopoietic colony-stimulating factors: Leo Sachs (1924-2013).

Sela M, Groner Y.

Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1664-5. doi: 10.1073/pnas.1324228111. Epub 2014 Jan 27. No abstract available.

20.

An in vivo method for measuring the adsorption of plasma proteins to titanium in humans.

Kohavi D, Badihi L, Rosen G, Steinberg D, Sela MN.

Biofouling. 2013;29(10):1215-24. doi: 10.1080/08927014.2013.834332. Epub 2013 Oct 3.

PMID:
24088083
21.

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2.

Maron R, Schechter B, Mancini M, Mahlknecht G, Yarden Y, Sela M.

Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15389-94. doi: 10.1073/pnas.1313857110. Epub 2013 Sep 3.

22.

Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm.

Oettinger-Barak O, Dashper SG, Catmull DV, Adams GG, Sela MN, Machtei EE, Reynolds EC.

J Oral Microbiol. 2013 May 8;5. doi: 10.3402/jom.v5i0.20320. Print 2013.

23.

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.

Mahlknecht G, Maron R, Mancini M, Schechter B, Sela M, Yarden Y.

Proc Natl Acad Sci U S A. 2013 May 14;110(20):8170-5. doi: 10.1073/pnas.1302594110. Epub 2013 Apr 29.

24.

Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR.

Ferraro DA, Gaborit N, Maron R, Cohen-Dvashi H, Porat Z, Pareja F, Lavi S, Lindzen M, Ben-Chetrit N, Sela M, Yarden Y.

Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1815-20. doi: 10.1073/pnas.1220763110. Epub 2013 Jan 14.

25.

Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.

Aharoni R, Sasson E, Blumenfeld-Katzir T, Eilam R, Sela M, Assaf Y, Arnon R.

Exp Neurol. 2013 Feb;240:130-44. doi: 10.1016/j.expneurol.2012.11.004. Epub 2012 Nov 12.

PMID:
23153580
26.

Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.

Aharoni R, Saada R, Eilam R, Hayardeny L, Sela M, Arnon R.

J Neuroimmunol. 2012 Oct 15;251(1-2):14-24. doi: 10.1016/j.jneuroim.2012.06.005. Epub 2012 Jun 28.

PMID:
22749337
27.

Wettability versus electrostatic forces in fibronectin and albumin adsorption to titanium surfaces.

Kohavi D, Badihi Hauslich L, Rosen G, Steinberg D, Sela MN.

Clin Oral Implants Res. 2013 Sep;24(9):1002-8. doi: 10.1111/j.1600-0501.2012.02508.x. Epub 2012 Jun 15.

PMID:
22697368
28.
29.

The adhesion of oral bacteria to modified titanium surfaces: role of plasma proteins and electrostatic forces.

Badihi Hauslich L, Sela MN, Steinberg D, Rosen G, Kohavi D.

Clin Oral Implants Res. 2013 Aug;24 Suppl A100:49-56. doi: 10.1111/j.1600-0501.2011.02364.x. Epub 2011 Dec 13.

PMID:
22150723
30.

Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance.

Emde A, Mahlknecht G, Maslak K, Ribba B, Sela M, Possinger K, Yarden Y.

Transl Oncol. 2011 Oct;4(5):293-300. Epub 2011 Oct 1.

31.

Sequential phosphorylation of SLP-76 at tyrosine 173 is required for activation of T and mast cells.

Sela M, Bogin Y, Beach D, Oellerich T, Lehne J, Smith-Garvin JE, Okumura M, Starosvetsky E, Kosoff R, Libman E, Koretzky G, Kambayashi T, Urlaub H, Wienands J, Chernoff J, Yablonski D.

EMBO J. 2011 Jul 1;30(15):3160-72. doi: 10.1038/emboj.2011.213.

32.

Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.

Witsch EJ, Mahlknecht G, Wakim J, Sertchook R, Bublil E, Yarden Y, Sela M.

Int Immunol. 2011 Jun;23(6):391-403. doi: 10.1093/intimm/dxr028. Epub 2011 May 19.

33.

[Surgical treatment of maxillary tumors].

Horowitz G, Gil Z, Kavel O, Smith D, Sela M, Abargel A, Fliss D.

Harefuah. 2010 Nov;149(11):704-7, 749. Hebrew.

PMID:
21250410
34.

Enhancement effect of water associated with natural organic matter (NOM) on organic compound-NOM interactions: a case study with carbamazepine.

Borisover M, Sela M, Chefetz B.

Chemosphere. 2011 Mar;82(10):1454-60. doi: 10.1016/j.chemosphere.2010.11.035. Epub 2010 Dec 7.

PMID:
21138776
35.

Combining epitope-distinct antibodies to HER2: cooperative inhibitory effects on invasive growth.

Emde A, Pradeep CR, Ferraro DA, Ben-Chetrit N, Sela M, Ribba B, Kam Z, Yarden Y.

Oncogene. 2011 Apr 7;30(14):1631-42. doi: 10.1038/onc.2010.547. Epub 2010 Dec 6.

36.

Molecular anthropology meets genetic medicine to treat blindness in the North African Jewish population: human gene therapy initiated in Israel.

Banin E, Bandah-Rozenfeld D, Obolensky A, Cideciyan AV, Aleman TS, Marks-Ohana D, Sela M, Boye S, Sumaroka A, Roman AJ, Schwartz SB, Hauswirth WW, Jacobson SG, Hemo I, Sharon D.

Hum Gene Ther. 2010 Dec;21(12):1749-57. doi: 10.1089/hum.2010.047. Epub 2010 Nov 3.

PMID:
20604683
37.

Roles for growth factors in cancer progression.

Witsch E, Sela M, Yarden Y.

Physiology (Bethesda). 2010 Apr;25(2):85-101. doi: 10.1152/physiol.00045.2009. Review.

38.

Cytokines levels, severity of acute mucositis and the need of PEG tube installation during chemo-radiation for head and neck cancer--a prospective pilot study.

Meirovitz A, Kuten M, Billan S, Abdah-Bortnyak R, Sharon A, Peretz T, Sela M, Schaffer M, Barak V.

Radiat Oncol. 2010 Feb 25;5:16. doi: 10.1186/1748-717X-5-16.

39.

Involvement of Toll-like receptors 2 and 4 in the innate immune response to Treponema denticola and its outer sheath components.

Nussbaum G, Ben-Adi S, Genzler T, Sela M, Rosen G.

Infect Immun. 2009 Sep;77(9):3939-47. doi: 10.1128/IAI.00488-09. Epub 2009 Jul 13.

40.

Degradation of collagen-guided tissue regeneration membranes by proteolytic enzymes of Porphyromonas gingivalis and its inhibition by antibacterial agents.

Sela MN, Babitski E, Steinberg D, Kohavi D, Rosen G.

Clin Oral Implants Res. 2009 May;20(5):496-502. doi: 10.1111/j.1600-0501.2008.01678.x. Epub 2009 Mar 3.

PMID:
19302237
41.

Pressure earring as an adjunct to surgical removal of earlobe keloids.

Savion Y, Sela M, Sharon-Buller A.

Dermatol Surg. 2009 Mar;35(3):490-2. doi: 10.1111/j.1524-4725.2009.01074.x. Epub 2009 Feb 22. No abstract available.

PMID:
19250308
42.

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis.

Ben-Kasus T, Schechter B, Lavi S, Yarden Y, Sela M.

Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3294-9. doi: 10.1073/pnas.0812059106. Epub 2009 Feb 13.

43.
44.

Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.

Aharoni R, Herschkovitz A, Eilam R, Blumberg-Hazan M, Sela M, Bruck W, Arnon R.

Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11358-63. doi: 10.1073/pnas.0804632105. Epub 2008 Aug 4.

45.

Prefabricated pressure earring for earlobe keloids.

Savion Y, Sela M.

J Prosthet Dent. 2008 May;99(5):406-7. doi: 10.1016/S0022-3913(08)60091-8. No abstract available.

PMID:
18456052
46.

The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligand.

Ben-David H, Sharabi A, Dayan M, Sela M, Mozes E.

Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17459-64. Epub 2007 Oct 23.

47.

Cancer therapeutic antibodies come of age: targeting minimal residual disease.

Ben-Kasus T, Schechter B, Sela M, Yarden Y.

Mol Oncol. 2007 Jun;1(1):42-54. doi: 10.1016/j.molonc.2007.01.003. Epub 2007 Mar 14. Review.

49.

Adsorption of human plasma proteins to modified titanium surfaces.

Sela MN, Badihi L, Rosen G, Steinberg D, Kohavi D.

Clin Oral Implants Res. 2007 Oct;18(5):630-8. Epub 2007 Apr 30.

PMID:
17484735
50.

An acrylic resin prosthesis for obturation of an orocutaneous fistula.

Sharon-Buller A, Sela M.

J Prosthet Dent. 2007 Mar;97(3):179-80. No abstract available.

PMID:
17394917

Supplemental Content

Support Center